文献速递血液透析通路

结扎还是保留:肾移植受者动静脉瘘关闭对心脏与移植肾功能影响的Meta分析

To Ligate or Not to Ligate: A Meta-analysis of Cardiac Effects and Allograft Function following Arteriovenous Fistula Closure in Renal Transplant Recipients.
PubMed 文献 · Ann Vasc Surg · 2019-09-16

该系统评价与Meta分析检索截至2019年1月的文献,比较肾移植受者动静脉瘘闭塞与通畅时的心脏收缩舒张功能及移植肾功能。结果显示瘘闭塞者左心室质量指数和左心室舒张末期内径更低,血清肌酐更低,射血分数无差异。提示移植肾功能良好者可考虑关闭动静脉瘘。

要点

  • 肾移植后动静脉瘘闭塞者左心室质量指数和左心室舒张末期内径低于通畅者。
  • 瘘闭塞者血清肌酐低于通畅者,射血分数两组无差异。
  • 移植肾功能良好者或可考虑关闭动静脉瘘。

核心结论

  • 动静脉瘘关闭可改善心脏形态并带来更好的移植肾功能。
  • 对移植肾功能良好的患者可考虑关闭动静脉瘘。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、EMBASE和Cochrane Library截至2019年1月的合格研究。
  • 主要比较动静脉瘘闭塞与通畅患者的左心室质量指数、左心室舒张末期内径、射血分数和血清肌酐差异。

主要发现

  • 瘘闭塞者左心室质量指数低于通畅者,合并均差为21.67(95%CI 19.94至23.39,P<0.001)。
  • 瘘闭塞者左心室舒张末期内径低于通畅者,合并均差为2.75(95%CI 1.47至4.04,P<0.001)。
  • 瘘闭塞者血清肌酐低于通畅者,合并均差为0.10(95%CI 0.04至0.17,P=0.003)。
  • 两组射血分数无差异,合并均差为0.84(95%CI -0.85至2.53,P=0.33)。

临床怎么用

  • 对移植肾功能良好且存在动静脉瘘的肾移植受者,可个体化评估关闭瘘的获益。
  • 决策时应结合心脏形态学改变和移植肾功能综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are no available guidelines regarding preserving or ligating an arteriovenous fistula following successful kidney transplantation. Therefore, we performed a meta-analysis to formulate a clear opinion regarding the status of arteriovenous fistula in renal allograft recipients. METHODS: We performed an electronic literature search of PubMed, EMBASE, and the Cochrane Library for eligible studies up to January 2019. We aimed to systematically evaluate cardiac systolic and diastolic function and allograft function after arteriovenous fistula closure. The primary outcome was the differences in left ventricular mass index, left ventricular end-diastolic diameter, ejection fraction, and serum creatinine levels between patients with occluded arteriovenous fistula versus patent arteriovenous fistula. RESULTS: Renal transplant recipients with occluded arteriovenous fistula had lower left ventricular mass index values and left ventricular end-diastolic diameter compared with those with patent arteriovenous fistula. The pooled mean differences were 21.67 (95% confidence interval [CI] 19.94 to 23.39, P < 0.001) and 2.75 (95% CI 1.47 to 4.04, P < 0.001), respectively. Patients with occluded arteriovenous fistula also had lower serum creatinine levels versus those with patent arteriovenous fistula. The pooled mean difference was 0.10 (95% CI 0.04 to 0.17, P = 0.003). We saw no difference regarding ejection fraction between the groups. The pooled mean difference was 0.84 (95% CI -0.85 to 2.53, P = 0.33). CONCLUSIONS: Our meta-analysis demonstrated that arteriovenous fistula closure improves cardiac morphology and has better kidney graft function. Arteriovenous fistula closure may be considered in patients with a well-functioning allograft.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zheng H, Bu S, Song Y, et al. To Ligate or Not to Ligate: A Meta-analysis of Cardiac Effects and Allograft Function following Arteriovenous Fistula Closure in Renal Transplant Recipients. Ann Vasc Surg. 2019. PMID: 31536798. doi:10.1016/j.avsg.2019.06.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。